-
July 1, 2022 Psychedelic Business Spotlight – July 1This week in psychedelic stock news: MindMed downplays delisiting fears; Red Light Holland teams with...
-
July 1, 2022 MindMed Reassures Investors over Nasdaq Delisting FearsIn a Reddit AMA, MindMed CEO Robert Barrow says Nasdaq delisting is not “a risk...
-
July 1, 2022 Colorado to Legalize Psychedelics?A Colorado initiative gives voters the power to legalize psychedelics and psilocybin therapy this November.
-
June 24, 2022 This Week in Psychedelic Stocks: Compass Pathways Wins Patent Battle, MindMed Patents Candy Flipping, and More!This week in psychedelic stock news, there are big patent developments for Compass, MindMed and...
-
June 24, 2022 Compass Pathways Psilocybin Patent UpheldCompass Pathways scores a major victory in their bid to patent Comp 360, a proprietary...
-
June 21, 2022 DMT is Effective at Treating Depression, New Study FindsDMT is a powerful hallucinogen that can conjure visions of entities and alien worlds, but...
-
June 17, 2022 Psychedelic Business Spotlight – June 17This week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin...
-
June 16, 2022 The Four Psychedelics ETFs Capturing Investor AttentionDespite an overarching shared thesis, the four psychedelics ETFs differ in philosophy, strategy, execution, and...
-
June 10, 2022 Psychedelic Business Spotlight – June 10This week in psychedelic business news: Cybin acquires a Phase 1 DMT trial from Entheon;...
-
June 8, 2022 The History of LSD: A Story of Self-ExperimentationDespite the LSD experience lasting only two hours, Hofmann was amazed at the power of...
